Stay updated with breaking news from Offlabel use. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
bret: but breaking tonight, a pair of journalists who were permitted to see through sources internal communications at twitter testified today before a house committee on the so-called weaponization of the federal government. republicans who control that committee are trying to show a link between censorship of conservatives, the biden administration, and the fbi. democrats today tried to pushback in a fiery hearing. correspondent david spunt takes a look tonight from the justice department. good evening, david. good evening to you. today s hearing delivered on a promise from house republicans to expose what was going on at twitter behind the scenes leading up to and after the 2020 election and, as we expected today, things got tense. can discuss. no one has yielded the gentle lady is out of order. and she is out of order because he interrupted. gentle lady is not recognized. you are not recognized. he has not said that. the new house subcommittee on ....
Doctor about ozempic in 2020. she says he eventually prescribed it, but kept her on a low dose for a year, even though her weight wasn t changing. so she asked about a higher dose or other medications. you felt like you needed to keep raising the issue? that s it. i have seen physicians who almost seem afraid to be proactive with people who are overweight. and i think that really impedes getting access to good care. reporter: both ozempic and mounjaro are drugs for diabetes, but also used offlabel for weight loss. wegovy and zepbound are now the two versions of the drugs, specifically intended for fighting obesity. but as linda discovered, securing a prescription for any of these drugs can be a challenge. eli lilly s ceo david ricks says his company is now trying to change that. i think a lot of people think of obesity as an issue of will power. it s not. 40% of adult americans have excess weight or obesity. that s a big number. reporter: the pharmaceutical giant ....